Tag Archives: Gilead Sciences Inc

Regeneron initiates late stage coronavirus antibody cocktail test

Regeneron Pharmaceuticals said Monday that it started late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating Covid-19, sending its actions up to nearly 4%. The test, conducted in conjunction with the National Institute of Allergy and Infectious Diseases, would test the therapy’s ability to …

Read More »